# NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
> **ANDA204470** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-08-24
## Drug
- **FDA Application Number:** ANDA204470
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
- **Generic name:** Esomeprazole Magnesium
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM; NAPROXEN
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LABS FL INC
- **First approval:** 2022-08-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204470)
---
*MORVS · CC0 1.0*